Christoph Ulrich Correll MD
Child & Adolescent Psychiatry
Medical Director, Recognition and Prevention (RAP) Program, Department of Psychiatry, The Zucker Hillside Hospital Investigator, Center for Psychiatric Neuroscience, The Feinstein Institute for Medical Research Professor, Psychiatry and Molecular Medicine, Hofstra Northwell School of Medicine
Join to View Full Profile
The Zucker Hillside Hospital Dept of Psych75 59 263RD StreetGlen Oaks, NY 11004
Phone+1 718-470-4812
Dr. Correll is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Zucker School of Medicine at Hofstra/Northwell at Zucker Hillside HospitalFellowship, Child and Adolescent Psychiatry, 2001 - 2003
Free Univ Berlin- Fac MedClass of 1993
Long Island Jewish Medical CenterResidency, Psychiatry
Certifications & Licensure
NY State Medical License 2013 - 2026
Clinical Trials
- Treating Drug-Resistant Childhood Schizophrenia Start of enrollment: 2001 Oct 01
- Antidepressant and Antipsychotic to Treat Attenuated Positive and Negative Symptoms Start of enrollment: 2004 Mar 01
- Clinical Risk State for Bipolar Disorder in Adolescents Start of enrollment: 2009 Sep 01
Publications & Presentations
PubMed
- Risk of schizophrenia-spectrum disorders among individuals with eating disorders: a nation-wide cohort study.Adam F Kemp, Simon Anhøj, Anna Mejldal, Peter N Schøler, Rikke Wesselhoeft
European Neuropsychopharmacology. 2026-03-01 - All-cause and cause-specific mortality in people with mental disorders: a population-based study on risk evaluation, effect modifiers and excess life-years lost in Hon...Joe Kwun-Nam Chan, Ryan Cheuk-Yin Li, Oleguer Plana-Ripoll, Natalie C Momen, Christoph U Correll
European Neuropsychopharmacology. 2026-03-01 - 2 citationsLumateperone monotherapy for major depressive episodes associated with bipolar disorder: efficacy and safety in a randomized placebo-controlled trial.Christoph U Correll, Suresh Durgam, Susan G Kozauer, Hassan D Lakkis, Changzheng Chen
International Clinical Psychopharmacology. 2026-03-01
Journal Articles
- Association Between Cardiovascular Risk Factors and Cognitive Impairment in People with SchizophreniaChristoph Correll, MD, JAMA Psychiatry
- Effectiveness of Transdiagnostic Cognitive-Behavioral Psychotherapy Compared with Management as Usual for Youth with Common Mental Health ProblemsChristoph Correll, MD, JAMA Psychiatry
- Impact of Comprehensive Treatment for First Episode Psychosis on Substance Use Outcomes: A Randomized Controlled TrialCorinne Cather, Robert Rosenheck, Christoph U Correll, Psychiatry Research
Authored Content
- Management of Patients with Severe Mental Illness During the Coronavirus Disease 2019 PandemicJune 2020
- Management of Patients with Severe Mental Illness During the Coronavirus Disease 2019 PandemicJune 2020
- Management of Patients with Severe Mental Illness During the Coronavirus Disease 2019 PandemicJune 2020
Press Mentions
Deep TMS for Schizophrenia?January 20th, 2026- International Schizophrenia Experts Develop Consensus Criteria for RelapseOctober 9th, 2025
- New Long-Term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-'749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS ObservedSeptember 21st, 2025
Grant Support
- Project 4 AcisrNational Institute Of Mental Health2010–2012
- Project 1 AcisrNational Institute Of Mental Health2010–2012
- Adverse Events Unit (Research Methods Core)National Institute Of Mental Health2010–2012
- 3/3-Improving Metabolic Parameters Of Antipsychotic Child Treatment (IMPACT)National Institute Of Mental Health2008–2011
- Improving Metabolic Parameters Of Antipsychotic Child Treatment (IMPACT)National Center For Research Resources2010
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
